These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28104849)

  • 1. A half-billion-dollar bid to head off emerging diseases.
    Cohen J
    Science; 2017 Jan; 355(6322):237. PubMed ID: 28104849
    [No Abstract]   [Full Text] [Related]  

  • 2. Billion-dollar project aims to prep vaccines before epidemics hit.
    Butler D
    Nature; 2017 Jan; 541(7638):444-445. PubMed ID: 28128262
    [No Abstract]   [Full Text] [Related]  

  • 3. Calling the shots.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2017 Mar; 5(3):157. PubMed ID: 28163021
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to the emerging novel coronavirus outbreak.
    Kickbusch I; Leung G
    BMJ; 2020 Jan; 368():m406. PubMed ID: 32005675
    [No Abstract]   [Full Text] [Related]  

  • 5. Funding vaccines for emerging infectious diseases.
    Wong G; Qiu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lassa fever and global health security.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2018 Apr; 18(4):357. PubMed ID: 29582756
    [No Abstract]   [Full Text] [Related]  

  • 7. VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.
    Leblanc P; Moise L; Luza C; Chantaralawan K; Lezeau L; Yuan J; Field M; Richer D; Boyle C; Martin WD; Fishman JB; Berg EA; Baker D; Zeigler B; Mais DE; Taylor W; Coleman R; Warren HS; Gelfand JA; De Groot AS; Brauns T; Poznansky MC
    Hum Vaccin Immunother; 2014; 10(10):3022-38. PubMed ID: 25483693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reminder that public health is global: New Jersey moniotring for emerging communicable diseases.
    O'Dowd ME
    MD Advis; 2014; 7(4):24-7. PubMed ID: 25485817
    [No Abstract]   [Full Text] [Related]  

  • 9. Invited Editorial: MERS-CoV An Emerging Viral Zoonotic Disease: Three Years After and Counting.
    Memish ZA
    Recent Pat Antiinfect Drug Discov; 2014; 9(3):159-60. PubMed ID: 25851253
    [No Abstract]   [Full Text] [Related]  

  • 10. Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access.
    Phelan AL; Eccleston-Turner M; Rourke M; Maleche A; Wang C
    Lancet; 2020 Sep; 396(10254):800-802. PubMed ID: 32910908
    [No Abstract]   [Full Text] [Related]  

  • 11. Planning for the unexpected: Ebola virus, Zika virus, what's next?
    Welfare W; Wright E
    Br J Hosp Med (Lond); 2016 Dec; 77(12):704-707. PubMed ID: 27937012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging infectious diseases. Nipah virus (or a cousin) strikes again.
    Enserink M
    Science; 2004 Feb; 303(5661):1121. PubMed ID: 14976284
    [No Abstract]   [Full Text] [Related]  

  • 13. MERS vaccine is technically feasible, but is it commerically feasible?
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(6):1429-30. PubMed ID: 25396231
    [No Abstract]   [Full Text] [Related]  

  • 14. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.
    Oyarzun P; Ellis JJ; Gonzalez-Galarza FF; Jones AR; Middleton D; Boden M; Kobe B
    Vaccine; 2015 Mar; 33(10):1267-73. PubMed ID: 25629524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MERS infection in animals to be reported as an emerging disease.
    Vet Rec; 2014 Aug; 175(7):163. PubMed ID: 25125414
    [No Abstract]   [Full Text] [Related]  

  • 16. Legal Issues in Quarantine and Isolation for Control of Emerging Infectious Diseases.
    Kim C
    J Prev Med Public Health; 2016 Jan; 49(1):1-17. PubMed ID: 26841880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS).
    Lu L; Xia S; Ying T; Jiang S
    Emerg Microbes Infect; 2015 Jun; 4(6):e37. PubMed ID: 26954884
    [No Abstract]   [Full Text] [Related]  

  • 18. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus.
    Palacios R; Poland GA; Kalil J
    Vaccine; 2016 Apr; 34(20):2291-3. PubMed ID: 27015734
    [No Abstract]   [Full Text] [Related]  

  • 19. From plague to MERS: coordinating Australia's response to emerging infectious diseases.
    Firman J; Williams SA; Baggoley C
    Public Health Res Pract; 2016 Dec; 26(5):. PubMed ID: 27997933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of guinea pigs for assessing the efficacy of vaccines against Lassa fever].
    Firsova IV; Shatokhina IV; Borisevich IV; Evseev AA; Maksimov VA; Pantiukhov VB; Khmelev AL
    Vopr Virusol; 2003; 48(6):43-5. PubMed ID: 14708232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.